MUC5AC and neoplasm: CIC oncogenic fusions upregulate its targets—including the ETS variant transcription factor (ETV) 1/4/5 PEA3 family of ETS transcription factors, CCND2, and MUC5AC [3,12,13]—promoting tumor development and progression.